For: | Couñago F, Navarro-Martin A, Luna J, Rodríguez de Dios N, Rodríguez A, Casas F, García R, Gómez-Caamaño A, Contreras J, Serrano J. GOECP/SEOR clinical recommendations for lung cancer radiotherapy during the COVID-19 pandemic. World J Clin Oncol 2020; 11(8): 510-527 [PMID: 32879841 DOI: 10.5306/wjco.v11.i8.510] |
---|---|
URL: | https://www.wjgnet.com/2218-4333/full/v11/i8/510.htm |
Number | Citing Articles |
1 |
Monica-Emilia Chirilă, Ivica Ratosa, Gustavo Nader Marta, Philip Poortmans. Hypofractionated Postoperative Radiation Therapy for Breast Cancer – Do We Need More Evidence or Adapted Reimbursement Policies?. Journal of Medical and Radiation Oncology 2021; 1(1): 83 doi: 10.53011/JMRO.2021.01.09
|
2 |
David J. H. Bian, Siham Sabri, Bassam S. Abdulkarim. Interactions between COVID-19 and Lung Cancer: Lessons Learned during the Pandemic. Cancers 2022; 14(15): 3598 doi: 10.3390/cancers14153598
|
3 |
Benjamin Mou, Derek Hyde, Cynthia Araujo, Leigh Bartha, Alanah Bergman, Mitchell Liu. Implementation of Single-Fraction Lung Stereotactic Ablative Radiotherapy in a Multicenter Provincial Cancer Program During the COVID-19 Pandemic. Cureus 2021; doi: 10.7759/cureus.15598
|
4 |
Austin J. Bartl, Mary Mahoney, Mark W. Hennon, Sai Yendamuri, Gregory M. M. Videtic, Kevin L. Stephans, Shankar Siva, Mark K. Farrugia, Sung Jun Ma, Anurag K. Singh. Systematic Review of Single-Fraction Stereotactic Body Radiation Therapy for Early Stage Non-Small-Cell Lung Cancer and Lung Oligometastases: How to Stop Worrying and Love One and Done. Cancers 2022; 14(3): 790 doi: 10.3390/cancers14030790
|
5 |
Castalia Fernández, Arturo Navarro-Martin, Andrea Bobo, Joaquín Cabrera-Rodriguez, Patricia Calvo, Rodolfo Chicas-Sett, Javier Luna, Nuria Rodríguez de Dios, Felipe Couñago. Single-fraction stereotactic ablative body radiation therapy for primary and metastasic lung tumor: A new paradigm?. World Journal of Clinical Oncology 2022; 13(2): 101-115 doi: 10.5306/wjco.v13.i2.101
|
6 |
Zahra Siavashpour, Neda Goharpey, Mosayyeb Mobasheri. Radiotherapy based management during Covid-19 pandemic – A systematic review of presented consensus and guidelines. Critical Reviews in Oncology/Hematology 2021; 164: 103402 doi: 10.1016/j.critrevonc.2021.103402
|
7 |
Felix-Nikolai Oschinka Jegor Habermann, Daniela Schmitt, Thomas Failing, Jann Fischer, David Alexander Ziegler, Laura Anna Fischer, Niklas Josua Alt, Julian Muster, Sandra Donath, Andrea Hille, Markus Anton Schirmer, Manuel Guhlich, Rami A. El Shafie, Stefan Rieken, Martin Leu, Leif Hendrik Dröge. Patterns of Pretreatment Diagnostic Assessment in Patients Treated with Stereotactic Body Radiation Therapy (SBRT) for Non-Small Cell Lung Cancer (NSCLC): Special Characteristics in the COVID Pandemic and Influence on Outcomes. Current Oncology 2022; 29(2): 1080 doi: 10.3390/curroncol29020092
|
8 |
Debra Penrod, Brandon Hirsch. Nursing Care for Metastatic Bone Cancer: Trends for the Future. International Journal of Environmental Research and Public Health 2023; 20(15): 6483 doi: 10.3390/ijerph20156483
|
9 |
Salem Alfaifi, Vibhay Pareek, Julian Kim, Shrinivas Rathod, William Hunter, Ahmet Leylek, Naseer Ahmed, Sankar Venkataraman, Niranjan Venugopal, Amitava Chowdhury, Arbind Dubey, Saranya Kakumanu, Bashir Bashir. Moving towards single fraction peripheral lung stereotactic body radiation therapy: patient care during and after the global COVID-19 pandemic. Lung Cancer Management 2024; doi: 10.1080/17581966.2024.2367369
|
10 |
Prasenjit Chatterjee, Jibak Bhattacharya, Tanmay Ghosh, Biplap Sarkar, Monica-Emilia Chirilă, Sushmita Roy Chowdhury, Syamasis Bandyopadhyay, Jayaprakash Agarwal. Radiotherapy for Lung Cancer During the COVID Pandemic – A Narrative Review of Practical Recommendations. Journal of Medical and Radiation Oncology 2021; 1(1): 99 doi: 10.53011/JMRO.2021.01.10
|
11 |
Abrahams Ocanto, Xabier Mielgo-Rubio, Javier Luna Tirado, Nuria Linares Mesa, Marta López Valcárcel, Sara Pedraza, Victoria Vera Barragan, Patricia Valencia Nieto, Juan Zafra Martín, Felipe Couñago. Coronavirus disease 2019 and lung cancer: where are we?. Exploration of Targeted Anti-tumor Therapy 2023; : 1082 doi: 10.37349/etat.2023.00182
|
12 |
Hilâl Tekatli, Miguel A. Palacios, Famke L. Schneiders, Cornelis J.A Haasbeek, Ben J. Slotman, Frank J. Lagerwaard, Suresh Senan. Local control and toxicity after magnetic resonance imaging (MR)-guided single fraction lung stereotactic ablative radiotherapy. Radiotherapy and Oncology 2023; 187: 109823 doi: 10.1016/j.radonc.2023.109823
|
13 |
Therese MJ. Kang, Nicholas Hardcastle, Anurag K. Singh, Ben J. Slotman, Gregory M.M. Videtic, Kevin L. Stephans, Felipe Couñago, Alexander V. Louie, Matthias Guckenberger, Susan V. Harden, Nikki M. Plumridge, Shankar Siva. Practical considerations of single-fraction stereotactic ablative radiotherapy to the lung. Lung Cancer 2022; 170: 185 doi: 10.1016/j.lungcan.2022.06.014
|
14 |
Jordi Remon, Noemí Reguart, Rosario García-Campelo, Esther Conde, Carmen-María Lucena, Oscar Persiva, Arturo Navarro-Martin, Ramón Rami-Porta. Lung Cancer in Spain. Journal of Thoracic Oncology 2021; 16(2): 197 doi: 10.1016/j.jtho.2020.09.026
|
15 |
Antonio Piras, Valeria Venuti, Andrea D’Aviero, Davide Cusumano, Stefano Pergolizzi, Antonino Daidone, Luca Boldrini. Covid-19 and radiotherapy: a systematic review after 2 years of pandemic. Clinical and Translational Imaging 2022; 10(6): 611 doi: 10.1007/s40336-022-00513-9
|
16 |
Simon Moubarak, Diala Merheb, Lynn Basbous, Nathalie Chamseddine, Maroun Bou Zerdan, Hazem I Assi. COVID-19 and lung cancer: update on the latest screening, diagnosis, management and challenges. Journal of International Medical Research 2022; 50(9) doi: 10.1177/03000605221125047
|